You are here: Industry Insights > AstraZeneca

News List

AstraZeneca’s lupus drug fails to meet main goal in study financialexpress
September 03, 2018
AstraZeneca’s anifrolumab, which is given intravenously, was being developed for lupus, a chronic autoimmune disease with limited treatment options
AstraZeneca-backed studies reveal constant risk of CV events and death pharmaceutical
August 30, 2018
Findings from three real-world evidence clinical studies supported by AstraZeneca have indicated the need for better secondary prevention of long-term ischemic risk in people who have survived a heart attack.
AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD pharmafile
August 27, 2018
Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted disappointing results compared to a rival product......
AstraZeneca's Bevespi Aerosphere fails to outperform GlaxoSmithKline's Anoro Ellipta in COPD trial firstwordpharma
August 24, 2018
AstraZeneca on Thursday announced top-line results from a Phase IIIb study of patients with moderate to very severe chronic obstructive pulmonary disease (COPD).......
AstraZeneca pushes back move to new Cambridge headquarters to 2020 amid delays, rising costs firstwordpharma
August 23, 2018
AstraZeneca indicated Wednesday that it will not move into its new biomedical campus building in Cambridge, the UK until 2020 as a result of switching contractors.......
AstraZeneca gets further approval for Tagrisso in Japan pharmaphorum
August 22, 2018
AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment of patients with positive non-small cell lung cancer (NSCLC), further expanding its currently authorised use in this
Japan approves AstraZeneca's Tagrisso in EGFRm non-small cell lung cancer pharmafile
August 22, 2018
AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry of Health, Labour and Welfare (MHLW) as a first-line therapy in patients with inoperable or recurrent epidermal gro
AstraZeneca's Tagrisso gains approval in Japan for the first-line treatment of patients with NSCLC firstwordpharma
August 22, 2018
AstraZeneca announced Tuesday that the Japanese Ministry of Health, Labour and Welfare approved Tagrisso (osimertinib) for the first-line treatment of patients with inoperable or recurrent EGFR mutation-positive non-small-cell lung cancer (NSCLC).
AstraZeneca collaborates with Myriad Genetics for cancer therapy biospectrumasia
August 21, 2018
AstraZeneca is working in collaboration with the molecular diagnostics firm Myriad Genetics’ for its test myChoice HRD Plus to identify advanced ovarian cancer patients who might benefit from maintenance treatment using Lynparza (olaparib) and Avastin (be
AstraZeneca, its new HQ delayed and way over budget, weighs a construction partner swap: report fiercepharma
August 21, 2018
AstraZeneca has been planning to move thousands of employees into a new headquarters for years, but its ongoing construction project has suffered from repeated delays and cost overruns. Now, the company is making moves to sideline its chief contractor to

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page